Stock DNA
Diversified
INR 3,004 Cr (Small Cap)
11.00
31
4.85%
-0.03
13.64%
1.54
Total Returns (Price + Dividend) 
Latest dividend: 8.5 per share ex-dividend date: Sep-16-2025
Risk Adjusted Returns v/s 
Returns Beta
News

Balmer Lawrie’s Evaluation Revised Amidst Challenging Financial and Market Conditions
Balmer Lawrie has experienced a revision in its market assessment reflecting recent shifts in its financial performance and market dynamics. This adjustment highlights evolving perspectives on the company’s quality, valuation, financial trends, and technical outlook within the diversified sector.
Read More
Balmer Lawrie & Company Faces Bearish Momentum Amid Technical Shifts
Balmer Lawrie & Company has experienced a notable shift in its technical momentum, with recent evaluation adjustments signalling a bearish trend across multiple timeframes. The stock’s price movements and key technical indicators such as MACD, RSI, Bollinger Bands, and moving averages reveal a complex landscape for investors navigating the diversified sector.
Read More
Balmer Lawrie & Company Forms Death Cross, Signalling Potential Bearish Trend
Balmer Lawrie & Company has recently experienced a significant technical development as its 50-day moving average crossed below the 200-day moving average, a pattern commonly referred to as a Death Cross. This event often signals a shift towards a bearish trend, reflecting potential long-term weakness and a deterioration in the stock’s momentum.
Read More Announcements 
Closure of Trading Window
27-Jan-2026 | Source : BSEPrior Intimation for Board meeting to be held on 6th February 2026 and continuation of closure of trading window
Board Meeting Intimation for Prior Intimation For Board Meeting To Be Held On 6Th February 2026
27-Jan-2026 | Source : BSEBalmer Lawrie & Company Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/02/2026 inter alia to consider and approve In terms of Regulation 29 of the SEBI (LODR) Regulations 2015 it is hereby informed that a Meeting of the Board of Directors of the Company is scheduled to be held on Friday 6th February 2026 to inter-alia consider the approval of Unaudited Financial Results (both Standalone and Consolidated) for the third quarter and nine months ended on 31st December 2025. Further to our intimation dated 24th December 2025 it may be noted that as per the Companys Code of Conduct to Regulate Monitor and Report Trading by Designated Persons and Immediate Relative of Designated Persons framed pursuant to the provisions of SEBI (PIT) Regulations 2015 (as amended) the Trading Window of the Company which has already been closed for Designated Persons and their immediate relatives and Insider w.e.f. Thursday 1st January 2026 shall continue to remain closed till 48 hours after the declaration of the aforementioned Financial Results.
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
14-Jan-2026 | Source : BSECertificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations 2018 (as amended) for the quarter ended on 31st December 2025
Corporate Actions 
No Upcoming Board Meetings
Balmer Lawrie & Company Ltd has declared 85% dividend, ex-date: 16 Sep 25
No Splits history available
Balmer Lawrie & Company Ltd has announced 1:2 bonus issue, ex-date: 26 Dec 19
No Rights history available
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Dec 2025
Shareholding Compare (%holding) 
Non Institution
None
Held by 1 Schemes (0.0%)
Held by 55 FIIs (2.16%)
None
Balmer Lawrie Investments Limited (61.8%)
26.75%
Quarterly Results Snapshot (Consolidated) - Sep'25 - QoQ
QoQ Growth in quarter ended Sep 2025 is -6.64% vs 11.92% in Jun 2025
QoQ Growth in quarter ended Sep 2025 is -17.95% vs -8.28% in Jun 2025
Half Yearly Results Snapshot (Consolidated) - Sep'25
Growth in half year ended Sep 2025 is 3.06% vs 8.42% in Sep 2024
Growth in half year ended Sep 2025 is -0.68% vs 4.28% in Sep 2024
Nine Monthly Results Snapshot (Consolidated) - Dec'24
YoY Growth in nine months ended Dec 2024 is 8.22% vs 2.87% in Dec 2023
YoY Growth in nine months ended Dec 2024 is 1.61% vs 47.58% in Dec 2023
Annual Results Snapshot (Consolidated) - Mar'25
YoY Growth in year ended Mar 2025 is 7.54% vs 0.76% in Mar 2024
YoY Growth in year ended Mar 2025 is 10.93% vs 39.52% in Mar 2024